Trials / Completed
CompletedNCT06804044
Intermittent Fasting (IF) Has Gained Recognition as a Promising Weight Loss Approach That Improves Body Weight, Insulin Resistance, and Metabolism. While Standard Diets Are Common in PCOS Management, IF May Address the Underlying Causes of Weight Gain and Offer Additional Metabolic Benefits
Effects of Different Dietary Programs on Anthropometric Parameters in Women With Polycystic Ovary Syndrome
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 33 (actual)
- Sponsor
- Bahçeşehir University · Academic / Other
- Sex
- Female
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Not accepted
Summary
The goal of this clinical trial is to learn if dietary interventions works to improve anthropometric measures in women with PCOS. The main questions it aims to answer are: * Does intermittent fasting (IF) cause loss of body weight, fat and muscle mass? * Can IF be considered more effective to medical and standart nutrition therapy (SDT)? * What dietary problems do participants have when having IF diet? Participants will: * Follow IF, SDT, or no intervention for 8 weeks. * Visit the clinic once every 2 weeks for check ups with a total of 5 visits for intervention groups IF and STD, visit at the beginning, second week and at the end for control group * Keep dietary records
Detailed description
It was conducted in individuals who were diagnosed with PCOS as a result of clinical, biochemical and ultrasonographic medical evaluation by a gynecologist.
Conditions
- Polycystic Ovary Syndrome
- Weight Loss
- Intermittent Fasting
- Medical Nutrition Therapy
- Caloric Restriction
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Intermittent Fasting | A 16:8 intermittent fasting with a daytime eating window model was applied. |
| BEHAVIORAL | Standart Diet Therapy | Meal plan with 3 main meals and 3 snacks was applied. |
Timeline
- Start date
- 2022-11-30
- Primary completion
- 2023-05-30
- Completion
- 2024-01-24
- First posted
- 2025-01-31
- Last updated
- 2025-01-31
Locations
1 site across 1 country: Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT06804044. Inclusion in this directory is not an endorsement.